nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—P-Glycoprotein Inhibitors—Zonisamide—epilepsy syndrome	0.494	1	CiPCiCtD
Ticagrelor—ABCB1—epilepsy syndrome	0.103	1	CbGaD
Ticagrelor—ABCB1—Levetiracetam—epilepsy syndrome	0.0236	0.0906	CbGbCtD
Ticagrelor—ABCB1—Clobazam—epilepsy syndrome	0.0163	0.0628	CbGbCtD
Ticagrelor—ABCB1—Lamotrigine—epilepsy syndrome	0.0157	0.0605	CbGbCtD
Ticagrelor—ABCB1—Carbamazepine—epilepsy syndrome	0.0135	0.0521	CbGbCtD
Ticagrelor—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0129	0.0497	CbGbCtD
Ticagrelor—ABCB1—Phenytoin—epilepsy syndrome	0.0121	0.0467	CbGbCtD
Ticagrelor—CYP3A4—Trimethadione—epilepsy syndrome	0.012	0.0462	CbGbCtD
Ticagrelor—CYP3A4—Felbamate—epilepsy syndrome	0.012	0.0462	CbGbCtD
Ticagrelor—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0113	0.0434	CbGbCtD
Ticagrelor—ABCB1—Phenobarbital—epilepsy syndrome	0.0108	0.0416	CbGbCtD
Ticagrelor—ABCB1—Midazolam—epilepsy syndrome	0.0107	0.041	CbGbCtD
Ticagrelor—ABCB1—Diazepam—epilepsy syndrome	0.0103	0.0395	CbGbCtD
Ticagrelor—CYP3A4—Clonazepam—epilepsy syndrome	0.0102	0.0393	CbGbCtD
Ticagrelor—CYP3A4—Clobazam—epilepsy syndrome	0.00979	0.0376	CbGbCtD
Ticagrelor—CYP3A4—Rufinamide—epilepsy syndrome	0.00832	0.032	CbGbCtD
Ticagrelor—CYP3A4—Carbamazepine—epilepsy syndrome	0.00811	0.0312	CbGbCtD
Ticagrelor—CYP3A4—Primidone—epilepsy syndrome	0.00757	0.0291	CbGbCtD
Ticagrelor—CYP3A4—Phenytoin—epilepsy syndrome	0.00727	0.028	CbGbCtD
Ticagrelor—CYP3A4—Propofol—epilepsy syndrome	0.00678	0.0261	CbGbCtD
Ticagrelor—CYP3A4—Acetazolamide—epilepsy syndrome	0.00648	0.0249	CbGbCtD
Ticagrelor—CYP3A4—Phenobarbital—epilepsy syndrome	0.00648	0.0249	CbGbCtD
Ticagrelor—CYP3A4—Midazolam—epilepsy syndrome	0.00639	0.0246	CbGbCtD
Ticagrelor—CYP3A4—Diazepam—epilepsy syndrome	0.00615	0.0236	CbGbCtD
Ticagrelor—CYP3A4—Zonisamide—epilepsy syndrome	0.006	0.0231	CbGbCtD
Ticagrelor—CYP3A4—Valproic Acid—epilepsy syndrome	0.00485	0.0186	CbGbCtD
Ticagrelor—CYP3A4—Topiramate—epilepsy syndrome	0.00437	0.0168	CbGbCtD
Ticagrelor—Mediastinal disorder—Gabapentin—epilepsy syndrome	5.72e-05	0.000538	CcSEcCtD
Ticagrelor—Hypersensitivity—Zonisamide—epilepsy syndrome	5.71e-05	0.000537	CcSEcCtD
Ticagrelor—Vomiting—Midazolam—epilepsy syndrome	5.69e-05	0.000534	CcSEcCtD
Ticagrelor—Diarrhoea—Vigabatrin—epilepsy syndrome	5.69e-05	0.000534	CcSEcCtD
Ticagrelor—Asthenia—Felbamate—epilepsy syndrome	5.68e-05	0.000534	CcSEcCtD
Ticagrelor—Chest pain—Valproic Acid—epilepsy syndrome	5.68e-05	0.000533	CcSEcCtD
Ticagrelor—Haematuria—Topiramate—epilepsy syndrome	5.68e-05	0.000533	CcSEcCtD
Ticagrelor—Feeling abnormal—Lamotrigine—epilepsy syndrome	5.64e-05	0.00053	CcSEcCtD
Ticagrelor—Rash—Midazolam—epilepsy syndrome	5.64e-05	0.00053	CcSEcCtD
Ticagrelor—Dizziness—Fosphenytoin—epilepsy syndrome	5.64e-05	0.00053	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	5.64e-05	0.00053	CcSEcCtD
Ticagrelor—Dermatitis—Midazolam—epilepsy syndrome	5.64e-05	0.00053	CcSEcCtD
Ticagrelor—Vomiting—Levetiracetam—epilepsy syndrome	5.62e-05	0.000528	CcSEcCtD
Ticagrelor—Epistaxis—Topiramate—epilepsy syndrome	5.61e-05	0.000527	CcSEcCtD
Ticagrelor—Headache—Midazolam—epilepsy syndrome	5.61e-05	0.000527	CcSEcCtD
Ticagrelor—Pruritus—Felbamate—epilepsy syndrome	5.61e-05	0.000526	CcSEcCtD
Ticagrelor—Abdominal pain—Carbamazepine—epilepsy syndrome	5.6e-05	0.000526	CcSEcCtD
Ticagrelor—Body temperature increased—Carbamazepine—epilepsy syndrome	5.6e-05	0.000526	CcSEcCtD
Ticagrelor—Diarrhoea—Diazepam—epilepsy syndrome	5.6e-05	0.000526	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	5.6e-05	0.000526	CcSEcCtD
Ticagrelor—Rash—Levetiracetam—epilepsy syndrome	5.57e-05	0.000523	CcSEcCtD
Ticagrelor—Dermatitis—Levetiracetam—epilepsy syndrome	5.57e-05	0.000523	CcSEcCtD
Ticagrelor—Asthenia—Zonisamide—epilepsy syndrome	5.56e-05	0.000523	CcSEcCtD
Ticagrelor—Mental disorder—Gabapentin—epilepsy syndrome	5.56e-05	0.000523	CcSEcCtD
Ticagrelor—Headache—Levetiracetam—epilepsy syndrome	5.54e-05	0.00052	CcSEcCtD
Ticagrelor—Malnutrition—Gabapentin—epilepsy syndrome	5.53e-05	0.000519	CcSEcCtD
Ticagrelor—Angioedema—Pregabalin—epilepsy syndrome	5.51e-05	0.000517	CcSEcCtD
Ticagrelor—Hypersensitivity—Clonazepam—epilepsy syndrome	5.51e-05	0.000517	CcSEcCtD
Ticagrelor—Dizziness—Vigabatrin—epilepsy syndrome	5.5e-05	0.000516	CcSEcCtD
Ticagrelor—Confusional state—Valproic Acid—epilepsy syndrome	5.49e-05	0.000515	CcSEcCtD
Ticagrelor—Pruritus—Zonisamide—epilepsy syndrome	5.49e-05	0.000515	CcSEcCtD
Ticagrelor—Hypersensitivity—Phenytoin—epilepsy syndrome	5.47e-05	0.000514	CcSEcCtD
Ticagrelor—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	5.44e-05	0.000511	CcSEcCtD
Ticagrelor—Bradycardia—Topiramate—epilepsy syndrome	5.44e-05	0.000511	CcSEcCtD
Ticagrelor—Nausea—Propofol—epilepsy syndrome	5.43e-05	0.00051	CcSEcCtD
Ticagrelor—Vomiting—Fosphenytoin—epilepsy syndrome	5.42e-05	0.000509	CcSEcCtD
Ticagrelor—Diarrhoea—Felbamate—epilepsy syndrome	5.42e-05	0.000509	CcSEcCtD
Ticagrelor—Vertigo—Pregabalin—epilepsy syndrome	5.42e-05	0.000509	CcSEcCtD
Ticagrelor—Body temperature increased—Lamotrigine—epilepsy syndrome	5.41e-05	0.000509	CcSEcCtD
Ticagrelor—Abdominal pain—Lamotrigine—epilepsy syndrome	5.41e-05	0.000509	CcSEcCtD
Ticagrelor—Dizziness—Diazepam—epilepsy syndrome	5.41e-05	0.000508	CcSEcCtD
Ticagrelor—Syncope—Pregabalin—epilepsy syndrome	5.41e-05	0.000508	CcSEcCtD
Ticagrelor—Rash—Fosphenytoin—epilepsy syndrome	5.38e-05	0.000505	CcSEcCtD
Ticagrelor—Dermatitis—Fosphenytoin—epilepsy syndrome	5.37e-05	0.000505	CcSEcCtD
Ticagrelor—Haemoglobin—Topiramate—epilepsy syndrome	5.37e-05	0.000504	CcSEcCtD
Ticagrelor—Asthenia—Clonazepam—epilepsy syndrome	5.36e-05	0.000504	CcSEcCtD
Ticagrelor—Back pain—Gabapentin—epilepsy syndrome	5.35e-05	0.000502	CcSEcCtD
Ticagrelor—Headache—Fosphenytoin—epilepsy syndrome	5.34e-05	0.000502	CcSEcCtD
Ticagrelor—Haemorrhage—Topiramate—epilepsy syndrome	5.34e-05	0.000502	CcSEcCtD
Ticagrelor—Nervous system disorder—Valproic Acid—epilepsy syndrome	5.34e-05	0.000501	CcSEcCtD
Ticagrelor—Asthenia—Phenytoin—epilepsy syndrome	5.33e-05	0.0005	CcSEcCtD
Ticagrelor—Nausea—Midazolam—epilepsy syndrome	5.32e-05	0.000499	CcSEcCtD
Ticagrelor—Diarrhoea—Zonisamide—epilepsy syndrome	5.31e-05	0.000498	CcSEcCtD
Ticagrelor—Loss of consciousness—Pregabalin—epilepsy syndrome	5.3e-05	0.000498	CcSEcCtD
Ticagrelor—Asthenia—Oxcarbazepine—epilepsy syndrome	5.3e-05	0.000498	CcSEcCtD
Ticagrelor—Pruritus—Clonazepam—epilepsy syndrome	5.29e-05	0.000497	CcSEcCtD
Ticagrelor—Vomiting—Vigabatrin—epilepsy syndrome	5.29e-05	0.000497	CcSEcCtD
Ticagrelor—Skin disorder—Valproic Acid—epilepsy syndrome	5.29e-05	0.000497	CcSEcCtD
Ticagrelor—Urinary tract disorder—Topiramate—epilepsy syndrome	5.28e-05	0.000496	CcSEcCtD
Ticagrelor—Oedema peripheral—Topiramate—epilepsy syndrome	5.26e-05	0.000494	CcSEcCtD
Ticagrelor—Cough—Pregabalin—epilepsy syndrome	5.26e-05	0.000494	CcSEcCtD
Ticagrelor—Pruritus—Phenytoin—epilepsy syndrome	5.25e-05	0.000493	CcSEcCtD
Ticagrelor—Connective tissue disorder—Topiramate—epilepsy syndrome	5.25e-05	0.000493	CcSEcCtD
Ticagrelor—Nausea—Levetiracetam—epilepsy syndrome	5.25e-05	0.000493	CcSEcCtD
Ticagrelor—Rash—Vigabatrin—epilepsy syndrome	5.24e-05	0.000492	CcSEcCtD
Ticagrelor—Dizziness—Felbamate—epilepsy syndrome	5.24e-05	0.000492	CcSEcCtD
Ticagrelor—Dermatitis—Vigabatrin—epilepsy syndrome	5.24e-05	0.000492	CcSEcCtD
Ticagrelor—Urethral disorder—Topiramate—epilepsy syndrome	5.24e-05	0.000492	CcSEcCtD
Ticagrelor—Pruritus—Oxcarbazepine—epilepsy syndrome	5.23e-05	0.000491	CcSEcCtD
Ticagrelor—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.22e-05	0.00049	CcSEcCtD
Ticagrelor—Headache—Vigabatrin—epilepsy syndrome	5.21e-05	0.000489	CcSEcCtD
Ticagrelor—Hypertension—Pregabalin—epilepsy syndrome	5.21e-05	0.000489	CcSEcCtD
Ticagrelor—Vomiting—Diazepam—epilepsy syndrome	5.21e-05	0.000489	CcSEcCtD
Ticagrelor—Rash—Diazepam—epilepsy syndrome	5.16e-05	0.000485	CcSEcCtD
Ticagrelor—Dermatitis—Diazepam—epilepsy syndrome	5.16e-05	0.000484	CcSEcCtD
Ticagrelor—Chest pain—Pregabalin—epilepsy syndrome	5.13e-05	0.000482	CcSEcCtD
Ticagrelor—Dizziness—Zonisamide—epilepsy syndrome	5.13e-05	0.000482	CcSEcCtD
Ticagrelor—Headache—Diazepam—epilepsy syndrome	5.13e-05	0.000482	CcSEcCtD
Ticagrelor—Diarrhoea—Clonazepam—epilepsy syndrome	5.11e-05	0.00048	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	5.1e-05	0.000479	CcSEcCtD
Ticagrelor—Hypotension—Valproic Acid—epilepsy syndrome	5.09e-05	0.000478	CcSEcCtD
Ticagrelor—Asthenia—Carbamazepine—epilepsy syndrome	5.08e-05	0.000478	CcSEcCtD
Ticagrelor—Diarrhoea—Phenytoin—epilepsy syndrome	5.08e-05	0.000477	CcSEcCtD
Ticagrelor—Nausea—Fosphenytoin—epilepsy syndrome	5.07e-05	0.000476	CcSEcCtD
Ticagrelor—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.05e-05	0.000475	CcSEcCtD
Ticagrelor—Angioedema—Gabapentin—epilepsy syndrome	5.05e-05	0.000474	CcSEcCtD
Ticagrelor—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.05e-05	0.000474	CcSEcCtD
Ticagrelor—Vomiting—Felbamate—epilepsy syndrome	5.04e-05	0.000473	CcSEcCtD
Ticagrelor—Pruritus—Carbamazepine—epilepsy syndrome	5.01e-05	0.000471	CcSEcCtD
Ticagrelor—Rash—Felbamate—epilepsy syndrome	5e-05	0.000469	CcSEcCtD
Ticagrelor—Eye disorder—Topiramate—epilepsy syndrome	4.99e-05	0.000469	CcSEcCtD
Ticagrelor—Dermatitis—Felbamate—epilepsy syndrome	4.99e-05	0.000469	CcSEcCtD
Ticagrelor—Vertigo—Gabapentin—epilepsy syndrome	4.97e-05	0.000467	CcSEcCtD
Ticagrelor—Headache—Felbamate—epilepsy syndrome	4.96e-05	0.000466	CcSEcCtD
Ticagrelor—Confusional state—Pregabalin—epilepsy syndrome	4.96e-05	0.000466	CcSEcCtD
Ticagrelor—Cardiac disorder—Topiramate—epilepsy syndrome	4.96e-05	0.000466	CcSEcCtD
Ticagrelor—Syncope—Gabapentin—epilepsy syndrome	4.96e-05	0.000466	CcSEcCtD
Ticagrelor—Dizziness—Clonazepam—epilepsy syndrome	4.94e-05	0.000464	CcSEcCtD
Ticagrelor—Nausea—Vigabatrin—epilepsy syndrome	4.94e-05	0.000464	CcSEcCtD
Ticagrelor—Vomiting—Zonisamide—epilepsy syndrome	4.93e-05	0.000463	CcSEcCtD
Ticagrelor—Asthenia—Lamotrigine—epilepsy syndrome	4.91e-05	0.000462	CcSEcCtD
Ticagrelor—Dizziness—Phenytoin—epilepsy syndrome	4.91e-05	0.000461	CcSEcCtD
Ticagrelor—Rash—Zonisamide—epilepsy syndrome	4.89e-05	0.000459	CcSEcCtD
Ticagrelor—Paraesthesia—Valproic Acid—epilepsy syndrome	4.89e-05	0.000459	CcSEcCtD
Ticagrelor—Dermatitis—Zonisamide—epilepsy syndrome	4.89e-05	0.000459	CcSEcCtD
Ticagrelor—Dizziness—Oxcarbazepine—epilepsy syndrome	4.88e-05	0.000459	CcSEcCtD
Ticagrelor—Nausea—Diazepam—epilepsy syndrome	4.86e-05	0.000457	CcSEcCtD
Ticagrelor—Loss of consciousness—Gabapentin—epilepsy syndrome	4.86e-05	0.000456	CcSEcCtD
Ticagrelor—Headache—Zonisamide—epilepsy syndrome	4.86e-05	0.000456	CcSEcCtD
Ticagrelor—Dyspnoea—Valproic Acid—epilepsy syndrome	4.85e-05	0.000456	CcSEcCtD
Ticagrelor—Diarrhoea—Carbamazepine—epilepsy syndrome	4.85e-05	0.000455	CcSEcCtD
Ticagrelor—Angiopathy—Topiramate—epilepsy syndrome	4.85e-05	0.000455	CcSEcCtD
Ticagrelor—Pruritus—Lamotrigine—epilepsy syndrome	4.85e-05	0.000455	CcSEcCtD
Ticagrelor—Shock—Pregabalin—epilepsy syndrome	4.84e-05	0.000455	CcSEcCtD
Ticagrelor—Immune system disorder—Topiramate—epilepsy syndrome	4.83e-05	0.000453	CcSEcCtD
Ticagrelor—Nervous system disorder—Pregabalin—epilepsy syndrome	4.83e-05	0.000453	CcSEcCtD
Ticagrelor—Cough—Gabapentin—epilepsy syndrome	4.82e-05	0.000453	CcSEcCtD
Ticagrelor—Mediastinal disorder—Topiramate—epilepsy syndrome	4.82e-05	0.000452	CcSEcCtD
Ticagrelor—Dyspepsia—Valproic Acid—epilepsy syndrome	4.79e-05	0.00045	CcSEcCtD
Ticagrelor—Skin disorder—Pregabalin—epilepsy syndrome	4.78e-05	0.000449	CcSEcCtD
Ticagrelor—Hypertension—Gabapentin—epilepsy syndrome	4.77e-05	0.000448	CcSEcCtD
Ticagrelor—Vomiting—Clonazepam—epilepsy syndrome	4.75e-05	0.000446	CcSEcCtD
Ticagrelor—Vomiting—Phenytoin—epilepsy syndrome	4.72e-05	0.000443	CcSEcCtD
Ticagrelor—Rash—Clonazepam—epilepsy syndrome	4.71e-05	0.000443	CcSEcCtD
Ticagrelor—Dermatitis—Clonazepam—epilepsy syndrome	4.71e-05	0.000442	CcSEcCtD
Ticagrelor—Chest pain—Gabapentin—epilepsy syndrome	4.71e-05	0.000442	CcSEcCtD
Ticagrelor—Nausea—Felbamate—epilepsy syndrome	4.71e-05	0.000442	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.7e-05	0.000441	CcSEcCtD
Ticagrelor—Vomiting—Oxcarbazepine—epilepsy syndrome	4.7e-05	0.000441	CcSEcCtD
Ticagrelor—Fatigue—Valproic Acid—epilepsy syndrome	4.69e-05	0.000441	CcSEcCtD
Ticagrelor—Dizziness—Carbamazepine—epilepsy syndrome	4.69e-05	0.00044	CcSEcCtD
Ticagrelor—Diarrhoea—Lamotrigine—epilepsy syndrome	4.69e-05	0.00044	CcSEcCtD
Ticagrelor—Headache—Clonazepam—epilepsy syndrome	4.68e-05	0.00044	CcSEcCtD
Ticagrelor—Rash—Phenytoin—epilepsy syndrome	4.68e-05	0.00044	CcSEcCtD
Ticagrelor—Mental disorder—Topiramate—epilepsy syndrome	4.68e-05	0.00044	CcSEcCtD
Ticagrelor—Dermatitis—Phenytoin—epilepsy syndrome	4.68e-05	0.000439	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.67e-05	0.000439	CcSEcCtD
Ticagrelor—Rash—Oxcarbazepine—epilepsy syndrome	4.66e-05	0.000437	CcSEcCtD
Ticagrelor—Constipation—Valproic Acid—epilepsy syndrome	4.65e-05	0.000437	CcSEcCtD
Ticagrelor—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.65e-05	0.000437	CcSEcCtD
Ticagrelor—Headache—Phenytoin—epilepsy syndrome	4.65e-05	0.000437	CcSEcCtD
Ticagrelor—Malnutrition—Topiramate—epilepsy syndrome	4.65e-05	0.000437	CcSEcCtD
Ticagrelor—Headache—Oxcarbazepine—epilepsy syndrome	4.63e-05	0.000435	CcSEcCtD
Ticagrelor—Nausea—Zonisamide—epilepsy syndrome	4.61e-05	0.000433	CcSEcCtD
Ticagrelor—Hypotension—Pregabalin—epilepsy syndrome	4.6e-05	0.000432	CcSEcCtD
Ticagrelor—Confusional state—Gabapentin—epilepsy syndrome	4.55e-05	0.000427	CcSEcCtD
Ticagrelor—Dizziness—Lamotrigine—epilepsy syndrome	4.53e-05	0.000425	CcSEcCtD
Ticagrelor—Vomiting—Carbamazepine—epilepsy syndrome	4.51e-05	0.000423	CcSEcCtD
Ticagrelor—Back pain—Topiramate—epilepsy syndrome	4.5e-05	0.000423	CcSEcCtD
Ticagrelor—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.49e-05	0.000421	CcSEcCtD
Ticagrelor—Rash—Carbamazepine—epilepsy syndrome	4.47e-05	0.00042	CcSEcCtD
Ticagrelor—Dermatitis—Carbamazepine—epilepsy syndrome	4.46e-05	0.000419	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.45e-05	0.000418	CcSEcCtD
Ticagrelor—Nausea—Clonazepam—epilepsy syndrome	4.44e-05	0.000417	CcSEcCtD
Ticagrelor—Headache—Carbamazepine—epilepsy syndrome	4.44e-05	0.000417	CcSEcCtD
Ticagrelor—Shock—Gabapentin—epilepsy syndrome	4.44e-05	0.000417	CcSEcCtD
Ticagrelor—Nervous system disorder—Gabapentin—epilepsy syndrome	4.42e-05	0.000416	CcSEcCtD
Ticagrelor—Paraesthesia—Pregabalin—epilepsy syndrome	4.42e-05	0.000415	CcSEcCtD
Ticagrelor—Nausea—Phenytoin—epilepsy syndrome	4.41e-05	0.000414	CcSEcCtD
Ticagrelor—Dyspnoea—Pregabalin—epilepsy syndrome	4.39e-05	0.000412	CcSEcCtD
Ticagrelor—Nausea—Oxcarbazepine—epilepsy syndrome	4.39e-05	0.000412	CcSEcCtD
Ticagrelor—Skin disorder—Gabapentin—epilepsy syndrome	4.38e-05	0.000412	CcSEcCtD
Ticagrelor—Vomiting—Lamotrigine—epilepsy syndrome	4.36e-05	0.000409	CcSEcCtD
Ticagrelor—Rash—Lamotrigine—epilepsy syndrome	4.32e-05	0.000406	CcSEcCtD
Ticagrelor—Dermatitis—Lamotrigine—epilepsy syndrome	4.31e-05	0.000405	CcSEcCtD
Ticagrelor—Body temperature increased—Valproic Acid—epilepsy syndrome	4.3e-05	0.000404	CcSEcCtD
Ticagrelor—Abdominal pain—Valproic Acid—epilepsy syndrome	4.3e-05	0.000404	CcSEcCtD
Ticagrelor—Headache—Lamotrigine—epilepsy syndrome	4.29e-05	0.000403	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.25e-05	0.000399	CcSEcCtD
Ticagrelor—Fatigue—Pregabalin—epilepsy syndrome	4.24e-05	0.000398	CcSEcCtD
Ticagrelor—Hypotension—Gabapentin—epilepsy syndrome	4.22e-05	0.000396	CcSEcCtD
Ticagrelor—Nausea—Carbamazepine—epilepsy syndrome	4.21e-05	0.000395	CcSEcCtD
Ticagrelor—Constipation—Pregabalin—epilepsy syndrome	4.21e-05	0.000395	CcSEcCtD
Ticagrelor—Vertigo—Topiramate—epilepsy syndrome	4.18e-05	0.000392	CcSEcCtD
Ticagrelor—Syncope—Topiramate—epilepsy syndrome	4.17e-05	0.000392	CcSEcCtD
Ticagrelor—Loss of consciousness—Topiramate—epilepsy syndrome	4.09e-05	0.000384	CcSEcCtD
Ticagrelor—Nausea—Lamotrigine—epilepsy syndrome	4.07e-05	0.000382	CcSEcCtD
Ticagrelor—Cough—Topiramate—epilepsy syndrome	4.06e-05	0.000381	CcSEcCtD
Ticagrelor—Feeling abnormal—Pregabalin—epilepsy syndrome	4.05e-05	0.000381	CcSEcCtD
Ticagrelor—Paraesthesia—Gabapentin—epilepsy syndrome	4.05e-05	0.000381	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.02e-05	0.000378	CcSEcCtD
Ticagrelor—Dyspnoea—Gabapentin—epilepsy syndrome	4.02e-05	0.000378	CcSEcCtD
Ticagrelor—Hypertension—Topiramate—epilepsy syndrome	4.02e-05	0.000377	CcSEcCtD
Ticagrelor—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.01e-05	0.000377	CcSEcCtD
Ticagrelor—Dyspepsia—Gabapentin—epilepsy syndrome	3.97e-05	0.000373	CcSEcCtD
Ticagrelor—Chest pain—Topiramate—epilepsy syndrome	3.96e-05	0.000372	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.93e-05	0.000369	CcSEcCtD
Ticagrelor—Asthenia—Valproic Acid—epilepsy syndrome	3.91e-05	0.000367	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.9e-05	0.000366	CcSEcCtD
Ticagrelor—Fatigue—Gabapentin—epilepsy syndrome	3.89e-05	0.000365	CcSEcCtD
Ticagrelor—Abdominal pain—Pregabalin—epilepsy syndrome	3.89e-05	0.000365	CcSEcCtD
Ticagrelor—Body temperature increased—Pregabalin—epilepsy syndrome	3.89e-05	0.000365	CcSEcCtD
Ticagrelor—Constipation—Gabapentin—epilepsy syndrome	3.86e-05	0.000362	CcSEcCtD
Ticagrelor—Pruritus—Valproic Acid—epilepsy syndrome	3.85e-05	0.000362	CcSEcCtD
Ticagrelor—Confusional state—Topiramate—epilepsy syndrome	3.83e-05	0.000359	CcSEcCtD
Ticagrelor—Shock—Topiramate—epilepsy syndrome	3.73e-05	0.000351	CcSEcCtD
Ticagrelor—Diarrhoea—Valproic Acid—epilepsy syndrome	3.72e-05	0.00035	CcSEcCtD
Ticagrelor—Nervous system disorder—Topiramate—epilepsy syndrome	3.72e-05	0.00035	CcSEcCtD
Ticagrelor—Feeling abnormal—Gabapentin—epilepsy syndrome	3.72e-05	0.000349	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.69e-05	0.000347	CcSEcCtD
Ticagrelor—Skin disorder—Topiramate—epilepsy syndrome	3.69e-05	0.000346	CcSEcCtD
Ticagrelor—Hypersensitivity—Pregabalin—epilepsy syndrome	3.63e-05	0.00034	CcSEcCtD
Ticagrelor—Dizziness—Valproic Acid—epilepsy syndrome	3.6e-05	0.000338	CcSEcCtD
Ticagrelor—Abdominal pain—Gabapentin—epilepsy syndrome	3.57e-05	0.000335	CcSEcCtD
Ticagrelor—Body temperature increased—Gabapentin—epilepsy syndrome	3.57e-05	0.000335	CcSEcCtD
Ticagrelor—Hypotension—Topiramate—epilepsy syndrome	3.55e-05	0.000333	CcSEcCtD
Ticagrelor—Asthenia—Pregabalin—epilepsy syndrome	3.53e-05	0.000332	CcSEcCtD
Ticagrelor—Pruritus—Pregabalin—epilepsy syndrome	3.48e-05	0.000327	CcSEcCtD
Ticagrelor—Vomiting—Valproic Acid—epilepsy syndrome	3.46e-05	0.000325	CcSEcCtD
Ticagrelor—Rash—Valproic Acid—epilepsy syndrome	3.43e-05	0.000322	CcSEcCtD
Ticagrelor—Dermatitis—Valproic Acid—epilepsy syndrome	3.43e-05	0.000322	CcSEcCtD
Ticagrelor—Headache—Valproic Acid—epilepsy syndrome	3.41e-05	0.00032	CcSEcCtD
Ticagrelor—Paraesthesia—Topiramate—epilepsy syndrome	3.41e-05	0.00032	CcSEcCtD
Ticagrelor—Dyspnoea—Topiramate—epilepsy syndrome	3.38e-05	0.000318	CcSEcCtD
Ticagrelor—Diarrhoea—Pregabalin—epilepsy syndrome	3.37e-05	0.000316	CcSEcCtD
Ticagrelor—Dyspepsia—Topiramate—epilepsy syndrome	3.34e-05	0.000314	CcSEcCtD
Ticagrelor—Hypersensitivity—Gabapentin—epilepsy syndrome	3.32e-05	0.000312	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.28e-05	0.000308	CcSEcCtD
Ticagrelor—Fatigue—Topiramate—epilepsy syndrome	3.27e-05	0.000307	CcSEcCtD
Ticagrelor—Dizziness—Pregabalin—epilepsy syndrome	3.25e-05	0.000306	CcSEcCtD
Ticagrelor—Constipation—Topiramate—epilepsy syndrome	3.25e-05	0.000305	CcSEcCtD
Ticagrelor—Asthenia—Gabapentin—epilepsy syndrome	3.24e-05	0.000304	CcSEcCtD
Ticagrelor—Nausea—Valproic Acid—epilepsy syndrome	3.23e-05	0.000304	CcSEcCtD
Ticagrelor—Pruritus—Gabapentin—epilepsy syndrome	3.19e-05	0.0003	CcSEcCtD
Ticagrelor—Vomiting—Pregabalin—epilepsy syndrome	3.13e-05	0.000294	CcSEcCtD
Ticagrelor—Feeling abnormal—Topiramate—epilepsy syndrome	3.13e-05	0.000294	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.1e-05	0.000292	CcSEcCtD
Ticagrelor—Rash—Pregabalin—epilepsy syndrome	3.1e-05	0.000291	CcSEcCtD
Ticagrelor—Dermatitis—Pregabalin—epilepsy syndrome	3.1e-05	0.000291	CcSEcCtD
Ticagrelor—Diarrhoea—Gabapentin—epilepsy syndrome	3.09e-05	0.00029	CcSEcCtD
Ticagrelor—Headache—Pregabalin—epilepsy syndrome	3.08e-05	0.00029	CcSEcCtD
Ticagrelor—Body temperature increased—Topiramate—epilepsy syndrome	3e-05	0.000282	CcSEcCtD
Ticagrelor—Abdominal pain—Topiramate—epilepsy syndrome	3e-05	0.000282	CcSEcCtD
Ticagrelor—Dizziness—Gabapentin—epilepsy syndrome	2.98e-05	0.00028	CcSEcCtD
Ticagrelor—Nausea—Pregabalin—epilepsy syndrome	2.92e-05	0.000275	CcSEcCtD
Ticagrelor—Vomiting—Gabapentin—epilepsy syndrome	2.87e-05	0.000269	CcSEcCtD
Ticagrelor—Rash—Gabapentin—epilepsy syndrome	2.84e-05	0.000267	CcSEcCtD
Ticagrelor—Dermatitis—Gabapentin—epilepsy syndrome	2.84e-05	0.000267	CcSEcCtD
Ticagrelor—Headache—Gabapentin—epilepsy syndrome	2.83e-05	0.000265	CcSEcCtD
Ticagrelor—Hypersensitivity—Topiramate—epilepsy syndrome	2.8e-05	0.000263	CcSEcCtD
Ticagrelor—Asthenia—Topiramate—epilepsy syndrome	2.72e-05	0.000256	CcSEcCtD
Ticagrelor—Pruritus—Topiramate—epilepsy syndrome	2.69e-05	0.000252	CcSEcCtD
Ticagrelor—Nausea—Gabapentin—epilepsy syndrome	2.68e-05	0.000252	CcSEcCtD
Ticagrelor—Diarrhoea—Topiramate—epilepsy syndrome	2.6e-05	0.000244	CcSEcCtD
Ticagrelor—Dizziness—Topiramate—epilepsy syndrome	2.51e-05	0.000236	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—CHRM2—epilepsy syndrome	2.51e-05	0.000691	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—BDKRB1—epilepsy syndrome	2.51e-05	0.000691	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CX3CL1—epilepsy syndrome	2.51e-05	0.000691	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—ALB—epilepsy syndrome	2.5e-05	0.00069	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CDC42—epilepsy syndrome	2.45e-05	0.000675	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GABBR1—epilepsy syndrome	2.44e-05	0.000672	CbGpPWpGaD
Ticagrelor—Vomiting—Topiramate—epilepsy syndrome	2.41e-05	0.000227	CcSEcCtD
Ticagrelor—Rash—Topiramate—epilepsy syndrome	2.39e-05	0.000225	CcSEcCtD
Ticagrelor—Dermatitis—Topiramate—epilepsy syndrome	2.39e-05	0.000225	CcSEcCtD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	2.39e-05	0.000658	CbGpPWpGaD
Ticagrelor—Headache—Topiramate—epilepsy syndrome	2.38e-05	0.000223	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—AVP—epilepsy syndrome	2.37e-05	0.000654	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HRH3—epilepsy syndrome	2.34e-05	0.000645	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—OPRM1—epilepsy syndrome	2.3e-05	0.000635	CbGpPWpGaD
Ticagrelor—Nausea—Topiramate—epilepsy syndrome	2.25e-05	0.000212	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—CCR5—epilepsy syndrome	2.22e-05	0.000612	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CA13—epilepsy syndrome	2.2e-05	0.000608	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—JUN—epilepsy syndrome	2.19e-05	0.000604	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCR3—epilepsy syndrome	2.17e-05	0.000599	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.17e-05	0.000599	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	2.14e-05	0.000589	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ATP2A2—epilepsy syndrome	2.12e-05	0.000584	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NPY—epilepsy syndrome	2.12e-05	0.000584	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	2.1e-05	0.000579	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—AGT—epilepsy syndrome	2.06e-05	0.000568	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	2.05e-05	0.000565	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	2.05e-05	0.000565	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL2—epilepsy syndrome	2.04e-05	0.000563	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCL3—epilepsy syndrome	2.04e-05	0.000563	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CRH—epilepsy syndrome	2.04e-05	0.000563	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—OXT—epilepsy syndrome	2.04e-05	0.000563	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HSPB1—epilepsy syndrome	2.04e-05	0.000563	CbGpPWpGaD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.03e-05	0.000558	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCR5—epilepsy syndrome	2.02e-05	0.000556	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	1.99e-05	0.000547	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—HTR2A—epilepsy syndrome	1.97e-05	0.000544	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	1.97e-05	0.000544	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL1B—epilepsy syndrome	1.96e-05	0.00054	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	1.96e-05	0.00054	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	1.95e-05	0.000539	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CASP3—epilepsy syndrome	1.95e-05	0.000538	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.95e-05	0.000536	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	1.93e-05	0.000532	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	1.92e-05	0.00053	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—VEGFA—epilepsy syndrome	1.91e-05	0.000528	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.91e-05	0.000525	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TSC1—epilepsy syndrome	1.9e-05	0.000524	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PTK2B—epilepsy syndrome	1.9e-05	0.000524	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	1.87e-05	0.000516	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	1.87e-05	0.000516	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	1.87e-05	0.000516	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	1.87e-05	0.000516	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AGT—epilepsy syndrome	1.87e-05	0.000516	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NTRK2—epilepsy syndrome	1.85e-05	0.00051	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SST—epilepsy syndrome	1.85e-05	0.00051	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCR2—epilepsy syndrome	1.85e-05	0.00051	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—DUSP6—epilepsy syndrome	1.83e-05	0.000505	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ADRA2A—epilepsy syndrome	1.81e-05	0.000499	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PLAT—epilepsy syndrome	1.8e-05	0.000497	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	1.78e-05	0.000491	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—SRC—epilepsy syndrome	1.77e-05	0.000488	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.76e-05	0.000484	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	1.74e-05	0.00048	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—BDKRB2—epilepsy syndrome	1.74e-05	0.000479	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL12—epilepsy syndrome	1.74e-05	0.000479	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—POMC—epilepsy syndrome	1.74e-05	0.000478	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PRKCB—epilepsy syndrome	1.73e-05	0.000477	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—VEGFA—epilepsy syndrome	1.73e-05	0.000476	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6ST—epilepsy syndrome	1.72e-05	0.000475	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—JUNB—epilepsy syndrome	1.71e-05	0.00047	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CNR1—epilepsy syndrome	1.71e-05	0.00047	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PLCB1—epilepsy syndrome	1.7e-05	0.000469	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ADK—epilepsy syndrome	1.67e-05	0.00046	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CERS1—epilepsy syndrome	1.67e-05	0.00046	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—FAR1—epilepsy syndrome	1.67e-05	0.00046	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GLUD1—epilepsy syndrome	1.67e-05	0.00046	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PDXK—epilepsy syndrome	1.67e-05	0.00046	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—L2HGDH—epilepsy syndrome	1.67e-05	0.00046	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HTR7—epilepsy syndrome	1.66e-05	0.000459	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	1.66e-05	0.000458	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—VEGFA—epilepsy syndrome	1.66e-05	0.000457	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.64e-05	0.000453	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	1.64e-05	0.000451	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HBEGF—epilepsy syndrome	1.62e-05	0.000445	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	1.59e-05	0.000439	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AKT3—epilepsy syndrome	1.59e-05	0.000437	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—POMC—epilepsy syndrome	1.58e-05	0.000434	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ADAM10—epilepsy syndrome	1.55e-05	0.000427	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCL2—epilepsy syndrome	1.54e-05	0.000425	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	1.53e-05	0.000423	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PNPO—epilepsy syndrome	1.53e-05	0.000421	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—EPM2A—epilepsy syndrome	1.53e-05	0.000421	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GAMT—epilepsy syndrome	1.53e-05	0.000421	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NHLRC1—epilepsy syndrome	1.53e-05	0.000421	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	1.48e-05	0.000408	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	1.48e-05	0.000408	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—S100B—epilepsy syndrome	1.47e-05	0.000404	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	1.46e-05	0.000402	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SOCS3—epilepsy syndrome	1.45e-05	0.0004	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CDC42—epilepsy syndrome	1.45e-05	0.000399	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	1.42e-05	0.000392	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—QDPR—epilepsy syndrome	1.42e-05	0.000392	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CA4—epilepsy syndrome	1.42e-05	0.000392	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	1.42e-05	0.000391	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AVP—epilepsy syndrome	1.4e-05	0.000386	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.36e-05	0.000374	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—COX3—epilepsy syndrome	1.34e-05	0.000368	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HES1—epilepsy syndrome	1.33e-05	0.000365	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.32e-05	0.000364	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FYN—epilepsy syndrome	1.29e-05	0.000355	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—H2AFX—epilepsy syndrome	1.28e-05	0.000354	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MEF2C—epilepsy syndrome	1.28e-05	0.000353	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.27e-05	0.000351	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.27e-05	0.000349	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.27e-05	0.000349	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.27e-05	0.000349	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.27e-05	0.000349	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.27e-05	0.000349	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—YWHAZ—epilepsy syndrome	1.24e-05	0.000341	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NGF—epilepsy syndrome	1.22e-05	0.000338	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.22e-05	0.000337	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.21e-05	0.000333	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCR5—epilepsy syndrome	1.19e-05	0.000328	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.18e-05	0.000324	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HTR2A—epilepsy syndrome	1.17e-05	0.000321	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.16e-05	0.000319	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.16e-05	0.000319	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.16e-05	0.000319	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.15e-05	0.000317	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.11e-05	0.000307	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TSC2—epilepsy syndrome	1.11e-05	0.000305	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AGT—epilepsy syndrome	1.11e-05	0.000305	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—AKT1—epilepsy syndrome	1.1e-05	0.000303	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.09e-05	0.000301	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APOE—epilepsy syndrome	1.08e-05	0.000299	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GBE1—epilepsy syndrome	1.08e-05	0.000297	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	1.08e-05	0.000297	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KDR—epilepsy syndrome	1.06e-05	0.000293	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.04e-05	0.000286	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.03e-05	0.000284	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.03e-05	0.000284	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.03e-05	0.000284	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.03e-05	0.000284	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.03e-05	0.000284	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.03e-05	0.000284	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PRKCB—epilepsy syndrome	1.02e-05	0.000282	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6ST—epilepsy syndrome	1.02e-05	0.000281	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.01e-05	0.000279	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1e-05	0.000276	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—STXBP1—epilepsy syndrome	9.85e-06	0.000271	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	9.64e-06	0.000266	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NT5E—epilepsy syndrome	9.6e-06	0.000264	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALAD—epilepsy syndrome	9.6e-06	0.000264	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	9.55e-06	0.000263	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	9.42e-06	0.000259	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	9.42e-06	0.000259	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PNPO—epilepsy syndrome	9.42e-06	0.000259	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GAMT—epilepsy syndrome	9.42e-06	0.000259	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	9.37e-06	0.000258	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—POMC—epilepsy syndrome	9.31e-06	0.000257	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	9.15e-06	0.000252	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	9.15e-06	0.000252	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCL2—epilepsy syndrome	9.11e-06	0.000251	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	8.96e-06	0.000247	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ADSL—epilepsy syndrome	8.78e-06	0.000242	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CA4—epilepsy syndrome	8.75e-06	0.000241	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—QDPR—epilepsy syndrome	8.75e-06	0.000241	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	8.73e-06	0.00024	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GLUL—epilepsy syndrome	8.61e-06	0.000237	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	8.45e-06	0.000233	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	8.4e-06	0.000232	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FGF2—epilepsy syndrome	8.23e-06	0.000227	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—COX3—epilepsy syndrome	8.23e-06	0.000227	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	8.18e-06	0.000225	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	7.9e-06	0.000218	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	7.85e-06	0.000216	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	7.8e-06	0.000215	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PFKL—epilepsy syndrome	7.8e-06	0.000215	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	7.8e-06	0.000215	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	7.8e-06	0.000215	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	7.8e-06	0.000215	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	7.78e-06	0.000214	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AQP1—epilepsy syndrome	7.67e-06	0.000211	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RELA—epilepsy syndrome	7.64e-06	0.000211	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MTOR—epilepsy syndrome	7.5e-06	0.000207	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ATIC—epilepsy syndrome	7.14e-06	0.000197	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—UPB1—epilepsy syndrome	7.14e-06	0.000197	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NEU1—epilepsy syndrome	7.14e-06	0.000197	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	7.01e-06	0.000193	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—AKT1—epilepsy syndrome	6.96e-06	0.000192	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	6.94e-06	0.000191	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CHRM3—epilepsy syndrome	6.94e-06	0.000191	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CASP3—epilepsy syndrome	6.89e-06	0.00019	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	6.87e-06	0.000189	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—JUN—epilepsy syndrome	6.7e-06	0.000185	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GBE1—epilepsy syndrome	6.63e-06	0.000183	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	6.63e-06	0.000183	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP9—epilepsy syndrome	6.52e-06	0.00018	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AKT1—epilepsy syndrome	6.32e-06	0.000174	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	6.24e-06	0.000172	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	6.07e-06	0.000167	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SRC—epilepsy syndrome	6.01e-06	0.000166	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NT5E—epilepsy syndrome	5.91e-06	0.000163	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALAD—epilepsy syndrome	5.91e-06	0.000163	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—VEGFA—epilepsy syndrome	5.85e-06	0.000161	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ABCG2—epilepsy syndrome	5.66e-06	0.000156	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	5.64e-06	0.000155	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	5.64e-06	0.000155	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	5.52e-06	0.000152	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	5.51e-06	0.000152	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	5.48e-06	0.000151	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ADSL—epilepsy syndrome	5.41e-06	0.000149	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GLUL—epilepsy syndrome	5.3e-06	0.000146	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	5.22e-06	0.000144	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	5.21e-06	0.000143	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	4.94e-06	0.000136	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.87e-06	0.000134	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.73e-06	0.00013	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.71e-06	0.00013	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	4.71e-06	0.00013	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—BCHE—epilepsy syndrome	4.69e-06	0.000129	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	4.47e-06	0.000123	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PLCB1—epilepsy syndrome	4.42e-06	0.000122	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—TH—epilepsy syndrome	4.41e-06	0.000121	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	4.27e-06	0.000118	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	4.27e-06	0.000118	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AKT1—epilepsy syndrome	3.73e-06	0.000103	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HMOX1—epilepsy syndrome	3.68e-06	0.000101	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CAT—epilepsy syndrome	3.63e-06	0.0001	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.48e-06	9.6e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.4e-06	9.36e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.37e-06	9.3e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GPX1—epilepsy syndrome	3.28e-06	9.04e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.05e-06	8.39e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.9e-06	7.99e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.89e-06	7.96e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AGT—epilepsy syndrome	2.88e-06	7.93e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOE—epilepsy syndrome	2.82e-06	7.77e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.75e-06	7.59e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.72e-06	7.51e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TH—epilepsy syndrome	2.71e-06	7.48e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—POMC—epilepsy syndrome	2.42e-06	6.67e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.27e-06	6.24e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.24e-06	6.16e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALB—epilepsy syndrome	2.21e-06	6.08e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.17e-06	5.99e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.02e-06	5.57e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.93e-06	5.32e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.77e-06	4.89e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.74e-06	4.79e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.49e-06	4.11e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.36e-06	3.75e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.19e-06	3.28e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AKT1—epilepsy syndrome	9.71e-07	2.68e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5.98e-07	1.65e-05	CbGpPWpGaD
